These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34325613)

  • 1. Proteases, protease inhibitors and radiation carcinogenesis.
    Kennedy AR
    Int J Radiat Biol; 2023; 99(6):882-890. PubMed ID: 34325613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
    Kennedy AR
    Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
    Wan XS; Serota DG; Ware JH; Crowell JA; Kennedy AR
    Nutr Cancer; 2002; 43(2):167-73. PubMed ID: 12588697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Bowman-Birk inhibitor on rat colon carcinogenesis.
    Kennedy AR; Billings PC; Wan XS; Newberne PM
    Nutr Cancer; 2002; 43(2):174-86. PubMed ID: 12588698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate.
    Kennedy AR; Szuhaj BF; Newberne PM; Billings PC
    Nutr Cancer; 1993; 19(3):281-302. PubMed ID: 8346077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
    Zhang L; Wan XS; Donahue JJ; Ware JH; Kennedy AR
    Nutr Cancer; 1999; 33(2):165-73. PubMed ID: 10368812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemopreventive agents: protease inhibitors.
    Kennedy AR
    Pharmacol Ther; 1998 Jun; 78(3):167-209. PubMed ID: 9690817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum.
    Kennedy CW; Donahue JJ; Wan XS
    Nutr Cancer; 1996; 26(2):209-17. PubMed ID: 8875558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases.
    Clemente A; Moreno FJ; Marín-Manzano Mdel C; Jiménez E; Domoney C
    Mol Nutr Food Res; 2010 Mar; 54(3):396-405. PubMed ID: 19885848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity.
    Malkowicz SB; Liu SP; Broderick GA; Wein AJ; Kennedy AR; Levin RM
    Neurourol Urodyn; 2003; 22(1):54-7. PubMed ID: 12478602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor.
    Kennedy AR; Beazer-Barclay Y; Kinzler KW; Newberne PM
    Cancer Res; 1996 Feb; 56(4):679-82. PubMed ID: 8630994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteases occurring in the cell membrane: a possible cell receptor for the Bowman-Birk type of protease inhibitors.
    Yavelow J; Caggana M; Beck KA
    Cancer Res; 1987 Mar; 47(6):1598-601. PubMed ID: 3545448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells.
    Kennedy AR; Wan XS
    Prostate; 2002 Feb; 50(2):125-33. PubMed ID: 11816021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells.
    Wan XS; Hamilton TC; Ware JH; Donahue JJ; Kennedy AR
    Nutr Cancer; 1998; 31(1):8-17. PubMed ID: 9682243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalisation of the Bowman-Birk protease inhibitor by intestinal epithelial cells.
    Billings PC; Brandon DL; Habres JM
    Eur J Cancer; 1991; 27(7):903-8. PubMed ID: 1834126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of carcinogenesis by protease inhibitors.
    Kennedy AR
    Cancer Res; 1994 Apr; 54(7 Suppl):1999s-2005s. PubMed ID: 8137328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of various preparations of dietary protease inhibitors on oral carcinogenesis in hamsters induced by DMBA.
    Kennedy AR; Billings PC; Maki PA; Newberne P
    Nutr Cancer; 1993; 19(2):191-200. PubMed ID: 8502589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents.
    Clemente A; Arques Mdel C
    World J Gastroenterol; 2014 Aug; 20(30):10305-15. PubMed ID: 25132747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.
    Touil T; Ciric B; Ventura E; Shindler KS; Gran B; Rostami A
    J Neurol Sci; 2008 Aug; 271(1-2):191-202. PubMed ID: 18544456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice.
    Kennedy AR; Kritchevsky D; Shen WC
    Pharm Res; 2003 Dec; 20(12):1908-10. PubMed ID: 14725352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.